The latest thoracic oncology news
The stigma that patients face when diagnosed with lung cancer is associated with poorer psychosocial…
A new editorial paper was published in Oncotarget Volume 14 on May 26, 2023. In their new editorial,…
The combination of benmelstobart, anlotinib, and chemotherapy demonstrated significant benefits compared to placebo and chemotherapy…
Fresh discoveries about a type of immune cells could give lung cancer patients a more…
Lung cancer is the deadliest cancer in the United States, and 80% of lung cancer…
According to data from Statistics Korea, cancer accounted for the majority of deaths in Korea…
On August 9, 2023, the Food and Drug Administration granted regular approval to pralsetinib for adult…
More than 14,000 cases of lung cancer were diagnosed in Australia in 2022. Survival rates are the worst…
The ultra-soft tentacle, which measures just 2 millimetres in diameter and is controlled by magnets,…
A new landmark report highlights the case for improving uptake of next-generation sequencing (NGS) for lung…